Sort by:

select Language:



Туберкулез выявление, лечение и мониторинг по К.Томену: Вопросы и ответы

T. Frieden, Eds.: World Health Organization, (2004)


Поэтому уже давно возникала мысль о том,что подробный комментарий по вопросам научных знаний и практическогоопыта, лежащих в основе политики ВОЗ по борьбе с туберкулезом, являлся бысущественным элементом технического сотрудничества ВОЗ с ее государствамичленами. Данная книга, написанная в форме вопросов и ответов, являетсяпервым шагом в этом направлении. Я надеюсь, что она станет доступной длявсех специалистов, участвующих в борьбе с туберкулезом, организаторов здравоохранения и администраторов, ответственных за формирование и выполнение национальных программ борьбы с туберкулезом, а также всех медицинскихработников, ежедневно решающих конкретные задачи борьбы с туберкулезомна местах.
https://www.challengetb.org/publications/tools/ua/...


WHO Guidelines on tuberculosis infection prevention and control, 2019 update

World Health Organization (WHO), (2019)


The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions specific to preventing transmission of Mycobacterium tuberculosis bridging with the core components of infection prevention and control programmes at the national and acute health care facility level
https://apps.who.int/iris/bitstream/handle/10665/3...


WHO consolidated guidelines on drug-resistant tuberculosis treatment

World Health Organization WHO; Stop TB, (2019)


The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
https://apps.who.int/iris/bitstream/handle/10665/3...


Mejores prácticas para la atención de pacientes con tuberculosis

G. Williams, E. Alarcón, S. Jittimanee et al., (2017)


Guía para países de bajos ingresos. 2 edición
https://www.theunion.org/what-we-do/publications/t...


Management of Diabetes Mellitus-Tuberculosis – A Guide to the Essential Practice

Lin Yan, Anthony D Harries, Ajay M V Kumar, et al., Eds.: The International Union Against Tuberculosis and Lung Disease, (2018)


This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation.
https://www.theunion.org/what-we-do/publications/t...


Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries

G. Williams, E. Alarcón, S. Jittimanee et al., Eds.: The International Union Against Tuberculosis and Lung Disease, (2017)


2nd edition. The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
https://www.theunion.org/what-we-do/publications/t...


Medicines Catalog August 2018

Global Drug Facility, Eds.: World Health Organization WHO, Stop TB, (2018)


The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
http://stoptb.org/assets/documents/gdf/Medicines_C...


WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis

World Health Organization WHO, (2018)


The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
http://apps.who.int/iris/bitstream/10665/260494/1/...


Let's talk TB: a free, online book for primary care providers

Madhukar Pai, Eds.: GP clinics, (2018)


The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrated, and most include quizzes and CME questions for self learning. The 3rd edition includes new chapters on MDR-TB, adverse effects of TB drugs, adherence monitoring strategies, and nutritional support. There is also content on how to manage children with TB, care for patients co-infected with TB and HIV, how to read and interpret chest x-rays, and how to avoid common pitfalls in TB management. To download book chapters or the whole book go to the website: http://www.letstalktb.org/download/
http://www.letstalktb.org/wp-content/uploads/2015/...


41 hits